A Middle-Up Approach with Online Capillary Isoelectric Focusing/Mass Spectrometry for In-Depth Characterization of Cetuximab Charge Heterogeneity
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Previously, we reported a new online capillary isoelectric focusing/mass spectrometric (CIEF/MS) method for intact monoclonal antibody (mAb) charge variant analysis that uses an electrokinetically pumped sheath-flow nanospray ion source on a time-of-flight (TOF) MS with a pressure-assisted chemical mobilization. The direct online CIEF/MS method exhibited excellent resolution of charge variants conforming to those of imaged capillary isoelectric focusing with ultraviolet detection (iCIEF/UV). However, for complex mAbs, CIEF/MS spectra of the intact charge variant peaks may be too convoluted to be effectively interpreted. In the present study, we implemented a middle-up approach to enhance the capability of the CIEF/MS method for characterizing complex mAb charge variants by reducing sample complexity. To demonstrate such a strategy, we fragmented cetuximab through IdeS enzymatic cleavage and dithiothreitol (DTT) reduction. For the first time, online CIEF/MS resolved the complex charge variants of cetuximab at subunit level, corroborating the profiles obtained by iCIEF/UV. Furthermore, high-resolution TOF mass spectra with high mass accuracy were obtained for the eight charge variants separated by CIEF/MS after IdeS cleavage and for the 11 charge variants after IdeS digestion with subsequent DTT reduction. In-depth analyses revealed the identities of all charge variants and pinpointed the causes of charge heterogeneity, which are in accord with those reported in the literature. The main sources of charge heterogeneity of cetuximab were identified as terminal lysine on the Fc domain (up to one on each single-chain Fc), glycolylneuraminic acid residues on the Fd' domain (up to two on each Fd'), and likely several deamidation species on the Fd' domain. No charge heterogeneity contribution was found from light chain. The in-depth characterization of complex charge variants for cetuximab demonstrates the remarkable capability of this middle-up CIEF/MS approach. This novel workflow holds great potential for detecting and elucidating charge variants to help understand proteins with complex charge heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In another report, Dai and Zhang used cIEF with a middle-down strategy to reduce sample complexity to achieve characterization of the charge heterogeneity for the same monoclonal antibody93.”
From Recent trends of capillary electrophoresis‐mass spectrometry in proteomics research (2019) · cites this paper as [93]
Citations
Cites
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G
von Pawel-Rammingen, U. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1607 · Cited by 473
Qian, J., Liu, T., Yang, L., Daus, A., Crowley, R., & Zhou, Q. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.01.023 · Cited by 291
Vlasak, J., Bussat, M. C., Wang, S., Wagner-Rousset, E., Schaefer, M., Klinguer-Hamour, C., Kirchmeier, M., Corvaïa, N., Ionescu, R., & Beck, A. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.05.043 · Cited by 252
Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
Beck, A., Sanglier-Cianférani, S., & Van Dorsselaer, A. (2012) · Analytical Chemistry · doi:10.1021/ac3002885 · Cited by 247
Ayoub, D., Jabs, W., Resemann, A., Evers, W., Evans, C., Main, L., Baessmann, C., Wagner-Rousset, E., Suckau, D., & Beck, A. (2013) · mAbs · doi:10.4161/mabs.25423 · Cited by 184
A protease for 'middle-down' proteomics
Wu, C., Tran, J. C., Zamdborg, L., Durbin, K. R., Li, M., Ahlf, D. R., Early, B. P., Thomas, P. M., Sweedler, J. V., & Kelleher, N. L. (2012) · Nature Methods · doi:10.1038/nmeth.2074 · Cited by 169
Asparagine Deamidation Dependence on Buffer Type, pH, and Temperature
Pace, A. L., Wong, R. L., Zhang, Y. T., Kao, Y.-H., & Wang, Y. J. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23529 · Cited by 159
Self-citationA new tool for monoclonal antibody analysis
An, Y., Zhang, Y., Mueller, H.-M., Shameem, M., & Chen, X. (2014) · mAbs · doi:10.4161/mabs.28762 · Cited by 144
Self-citationFüssl, F., Cook, K., Scheffler, K., Farrell, A., Mittermayr, S., & Bones, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05241 · Cited by 132
Toward an Optimized Workflow for Middle-Down Proteomics
Cristobal, A., Marino, F., Post, H., van den Toorn, H. W. P., Mohammed, S., & Heck, A. J. R. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03756 · Cited by 130
Moorhouse, K. G., Nashabeh, W., Deveney, J., Bjork, N., Mulkerrin, M. G., & Ryskamp, T. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(97)00178-7 · Cited by 125
Dai, J., Lamp, J., Xia, Q., & Zhang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04608 · Cited by 123
Self-citationChevreux, G., Tilly, N., & Bihoreau, N. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.04.030 · Cited by 112
Sjögren, J., Olsson, F., & Beck, A. (2016) · The Analyst · doi:10.1039/c6an00071a · Cited by 109
D’Atri, V., Fekete, S., Beck, A., Lauber, M. A., & Guillarme, D. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04726 · Cited by 101
Stoll, D. R., Harmes, D. C., Staples, G. O., Potter, O. G., Dammann, C. T., Guillarme, D., & Beck, A. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00776 · Cited by 101
Santora, L. C., Krull, I. S., & Grant, K. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4275 · Cited by 95
Sorensen, M., Harmes, D. C., Stoll, D. R., Staples, G. O., Fekete, S., Guillarme, D., & Beck, A. (2016) · mAbs · doi:10.1080/19420862.2016.1203497 · Cited by 88
Sjögren, J., Cosgrave, E. F. J., Allhorn, M., Nordgren, M., Björk, S., Olsson, F., Fredriksson, S., & Collin, M. (2015) · Glycobiology · doi:10.1093/glycob/cwv047 · Cited by 83
Biacchi, M., Gahoual, R., Said, N., Beck, A., Leize-Wagner, E., & François, Y.-N. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00928 · Cited by 79
Jooß, K., Hühner, J., Kiessig, S., Moritz, B., & Neusüß, C. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0542-0 · Cited by 79
Gahoual, R., Biacchi, M., Chicher, J., Kühn, L., Hammann, P., Beck, A., Leize‐Wagner, E., & François, Y. (2014) · mAbs · doi:10.4161/mabs.36305 · Cited by 76
Wang, L., Bo, T., Zhang, Z., Wang, G., Tong, W., & Chen, D. D. Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02175 · Cited by 68
Capillary isoelectric focusing‐mass spectrometry: Coupling strategies and applications
Hühner, J., Lämmerhofer, M., & Neusüß, C. (2015) · Electrophoresis · doi:10.1002/elps.201500185 · Cited by 62
Subunit mass analysis for monitoring antibody oxidation
Sokolowska, I., Mo, J., Dong, J., Lewis, M. J., & Hu, P. (2017) · mAbs · doi:10.1080/19420862.2017.1279773 · Cited by 58
Goyon, A., D’Atri, V., Bobály, B., Wagner‐Rousset, E., Beck, A., Fekete, S., & Guillarme, D. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.05.010 · Cited by 58
Characterization of cetuximab Fc/2 dimers by off-line CZE-MS
François, Y., Biacchi, M., Saïd, N., Renard, C., Beck, A., Gahoual, R., & Leize‐Wagner, E. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.12.033 · Cited by 55
Lau, H., Pace, D., Yan, B., McGrath, T., Smallwood, S., Patel, K., Park, J., Park, S. S., & Latypov, R. F. (2010) · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · doi:10.1016/j.jchromb.2010.02.003 · Cited by 52
Wang, B., Gucinski, A. C., Keire, D. A., Buhse, L. F., & Boyne, M. T. (2013) · The Analyst · doi:10.1039/c3an36524g · Cited by 52
Kinoshita, M., Nakatsuji, Y., Suzuki, S., Hayakawa, T., & Kakehi, K. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.08.021 · Cited by 51
Faid, V., Leblanc, Y., Bihoreau, N., & Chevreux, G. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.11.046 · Cited by 50
Coupling imaged capillary isoelectric focusing with mass spectrometry using a nanoliter valve
Montealegre, C., & Neusüß, C. (2018) · Electrophoresis · doi:10.1002/elps.201800013 · Cited by 50
Ponniah, G., Nowak, C., Neill, A., & Liu, H. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.12.017 · Cited by 47
Tran, B. Q., Barton, C., Feng, J., Sandjong, A., Yoon, S. H., Awasthi, S., Liang, T., Khan, M. M., Kilgour, D. P. A., Goodlett, D. R., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.10.021 · Cited by 46
Trappe, A., Füssl, F., Carillo, S., Zaborowska, I., Meleady, P., & Bones, J. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.07.037 · Cited by 45
Biacchi, M., Said, N., Beck, A., Leize-Wagner, E., & François, Y.-N. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.02.064 · Cited by 41
Development of a fast workflow to screen the charge variants of therapeutic antibodies
Wagner‐Rousset, E., Fekete, S., Laura, M.-C., Colas, O., Corvaı̈a, N., Cianférani, S., Guillarme, D., & Beck, A. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.02.065 · Cited by 39
Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
Eakin, C. M., Miller, A. K., Kerr, J., Kung, J., & Wallace, A. M. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00087 · Cited by 38
Goyon, A., François, Y., Colas, O., Beck, A., Veuthey, J., & Guillarme, D. (2018) · Electrophoresis · doi:10.1002/elps.201800131 · Cited by 35
Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS
Liu, S., Gao, W., Wang, Y., He, Z., Feng, X., Liu, B., & Liu, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170013 · Cited by 33
King, C. A., Patel, R., Ponniah, G., Nowak, C., Neill, A., Gu, Z., & Liu, H. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.03.049 · Cited by 31
Kim, J., Jones, L., Taylor, L. D., Kannan, G., Jackson, F., Lau, H., Latypov, R. F., & Bailey, B. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.05.032 · Cited by 29
Upton, R., Bell, L., Guy, C. P., Caldwell, P., Estdale, S., Barran, P. E., & Firth, D. F. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02994 · Cited by 29
Wiegandt, A., & Meyer, B. (2014) · Analytical Chemistry · doi:10.1021/ac404043g · Cited by 28
Liu, H., Ren, W., Zong, L., Zhang, J., & Wang, Y. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.10.002 · Cited by 28
LC–MS analysis of polyclonal IgGs using IdeS enzymatic proteolysis for oxidation monitoring
Leblanc, Y., Romanin, M., Bihoreau, N., & Chevreux, G. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.04.053 · Cited by 26
Zhang, Z., Perrault, A. R., Zhao, Y., & Ding, J. H. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.03.031 · Cited by 24
Belov, A. M., Zang, L., Sebastiano, R., dos Santos, M. R. M., Bush, D. R., Karger, B. L., & Ivanov, A. R. (2018) · Electrophoresis · doi:10.1002/elps.201870132 · Cited by 2
Wu, G., Yu, C., Wang, W., & Wang, L. (2018) · Electrophoresis · doi:10.1002/elps.201870131 · Cited by 1
Cited by
Monitoring of immunoglobulin N- and O-glycosylation in health and disease
de Haan, N., Falck, D., & Wuhrer, M. (2019) · Glycobiology · doi:10.1093/glycob/cwz048 · Cited by 127
“Examples of enzymes used in these approaches are IdeS, which is expected to result in two Fc/2 fragments and one intact F(ab’)2 fragment by cleaving IgG under the hinge region, and GingisKHAN which results in one intact Fc and two intact Fab fragments by cleaving IgG above the hinge region (van der Burgt et al. 2019).”
BackgroundInfluentialRecent trends of capillary electrophoresis‐mass spectrometry in proteomics research
Gomes, F. P., & Yates, J. R. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21599 · Cited by 112
Recent advances (2019–2021) of capillary electrophoresis‐mass spectrometry for multilevel proteomics
Chen, D., McCool, E. N., Yang, Z., Shen, X., Lubeckyj, R. A., Xu, T., Wang, Q., & Sun, L. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21714 · Cited by 106
Füssl, F., Trappe, A., Carillo, S., Jakes, C., & Bones, J. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00185 · Cited by 95
Camperi, J., Goyon, A., Guillarme, D., Zhang, K., & Stella, C. (2020) · The Analyst · doi:10.1039/d0an01963a · Cited by 87
Metadata
- Authors
- Dai, J., & Zhang, Y.
- Affiliations
- Bristol-Myers Squibb (United States) (US)
- Corresponding author
- Dai, Jun
- Venue
- Analytical Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-19
- Volume
- 90
- Issue
- 24
- Pages
- 14527-14534
- ISSN
- 0003-2700 (ISSN-L)
- 1520-6882
- OpenAlex
- W2900473322
- Cited by
- 46
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 8
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Analytical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- cetuximab, charge heterogeneity, dithiothreitol reduction, deamidation, sample complexity reduction
- MeSH terms
- Cetuximab, Bacterial Proteins, Dithiothreitol, Immunoglobulin Fab Fragments, Isoelectric Focusing, Electrophoresis, Capillary, Spectrometry, Mass, Electrospray Ionization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.